1.
Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab.
Nilforushan Naveed, Es'haghi Acieh, Miraftabi Arezoo, Abolfathzadeh Navid, Banifatemi Mahammad
Br J OphthalmolDec 202011 citationsRandomized Controlled Trial
This study found that adding intravitreal bevacizumab to MMC-augmented trabeculectomy in diabetic patients led to lower IOP and fewer medications than MMC alone, suggesting improved surgical outcomes.